Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
calcium chloride + potassium chloride + sodium chloride + magnesium chloride + sodium acetate is a fixed-combination sterile intravenous electrolyte formulation marketed as **TPN Electrolytes** for use after dilution as an additive to total parenteral nutrition solutions. It supplies essential ions including sodium, potassium, calcium, magnesium, chloride, and acetate to help maintain electrolyte and acid-base homeostasis in adults receiving central venous nutritional support. The product is used as a maintenance electrolyte replenisher rather than a receptor-targeted therapy, and is specifically described as a concentrated, nonpyrogenic solution without phosphate, bacteriostat, antimicrobial agent, or added buffer. It has been associated with Hospira as manufacturer/developer and is used for prevention or treatment of electrolyte imbalance in the parenteral nutrition setting.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on calcium chloride + potassium chloride + sodium chloride + magnesium chloride + sodium acetate.